IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 359 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $68,040 | +10.6% | 1,500 | 0.0% | 0.05% | +13.6% |
| Q2 2023 | $61,545 | +14.8% | 1,500 | 0.0% | 0.04% | +10.0% |
| Q1 2023 | $53,610 | -5.4% | 1,500 | 0.0% | 0.04% | -9.1% |
| Q4 2022 | $56,655 | -14.2% | 1,500 | 0.0% | 0.04% | -17.0% |
| Q3 2022 | $66,000 | +17.9% | 1,500 | 0.0% | 0.05% | +65.6% |
| Q1 2022 | $56,000 | +21.7% | 1,500 | 0.0% | 0.03% | +28.0% |
| Q4 2021 | $46,000 | -8.0% | 1,500 | 0.0% | 0.02% | -13.8% |
| Q3 2021 | $50,000 | -16.7% | 1,500 | 0.0% | 0.03% | -12.1% |
| Q2 2021 | $60,000 | -10.4% | 1,500 | 0.0% | 0.03% | -19.5% |
| Q1 2021 | $67,000 | – | 1,500 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |